Biological and Immunological Characterization of a Functional L-HN Derivative of Botulinum Neurotoxin Serotype F
Author:
Li Zhiying12, Li Bolin1, Lu Jiansheng1, Liu Xuyang12, Tan Xiao13, Wang Rong1, Du Peng1, Yu Shuo1, Xu Qing3ORCID, Pang Xiaobin2, Yu Yunzhou1ORCID, Yang Zhixin1
Affiliation:
1. Beijing Institute of Biotechnology, Beijing 100071, China 2. Pharmaceutical College, Henan University, Kaifeng 475001, China 3. Institute of Life Science and Biotechnology, Beijing Jiaotong University, Beijing 100044, China
Abstract
Botulinum neurotoxins (BoNTs) can cause nerve paralysis syndrome in mammals and other vertebrates. BoNTs are the most toxic biotoxins known and are classified as Class A biological warfare agents. BoNTs are mainly divided into seven serotypes A-G and new neurotoxins BoNT/H and BoNT/X, which have similar functions. BoNT proteins are 150 kDa polypeptide consisting of two chains and three domains: the light chain (L, catalytic domain, 50 kDa) and the heavy chain (H, 100 kDa), which can be divided into an N-terminal membrane translocation domain (HN, 50 kDa) and a C-terminal receptor binding domain (Hc, 50 kDa). In current study, we explored the immunoprotective efficacy of each functional molecule of BoNT/F and the biological characteristics of the light chain-heavy N-terminal domain (FL-HN). The two structure forms of FL-HN (i.e., FL-HN-SC: single chain FL-HN and FL-HN-DC: di-chain FL-HN) were developed and identified. FL-HN-SC could cleave the vesicle associated membrane protein 2 (VAMP2) substrate protein in vitro as FL-HN-DC or FL. While only FL-HN-DC had neurotoxicity and could enter neuro-2a cells to cleave VAMP2. Our results showed that the FL-HN-SC had a better immune protection effect than the Hc of BoNT/F (FHc), which indicated that L-HN-SC, as an antigen, provided the strongest protective effects against BoNT/F among all the tested functional molecules. Further in-depth research on the different molecular forms of FL-HN suggested that there were some important antibody epitopes at the L-HN junction of BoNT/F. Thus, FL-HN-SC could be used as a subunit vaccine to replace the FHc subunit vaccine and/or toxoid vaccine, and to develop antibody immune molecules targeting L and HN domains rather than the FHc domain. FL-HN-DC could be used as a new functional molecule to evaluate and explore the structure and activity of toxin molecules. Further exploration of the biological activity and molecular mechanism of the functional FL-HN or BoNT/F is warranted.
Funder
Biosafety Research Project
Subject
Health, Toxicology and Mutagenesis,Toxicology
Reference58 articles.
1. Botulinum neurotoxins: Biology, pharmacology, and toxicology;Pirazzini;Pharmacol. Rev.,2017 2. Choudhury, S., Baker, M.R., Chatterjee, S., and Kumar, H. (2021). Botulinum toxin: An update on pharmacology and newer products in development. Toxins, 13. 3. Rossetto, O., and Montecucco, C. (2019). Tables of toxicity of botulinum and tetanus neurotoxins. Toxins, 11. 4. Rasetti-Escargueil, C., and Popoff, M.R. (2019). Antibodies and vaccines against botulinum toxins: Available measures and novel approaches. Toxins, 11. 5. Ben David, A., Barnea, A., Diamant, E., Dor, E., Schwartz, A., Torgeman, A., and Zichel, R. (2021). Small molecule receptor binding inhibitors with in vivo efficacy against botulinum neurotoxin serotypes a and e. Int. J. Mol. Sci., 22.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|